Vimarsana
Biggest News Aggregation in the World

Page 6 - Launch Dynamix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Launch Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Launch Dynamix Today - Breaking & Trending Today

US Dermatologists' Lack of Success with Current Treatment Options in Vitiligo Paves the Way for Pipeline Advanced Systemic Agents to Disrupt the Market, According to Spherix Global Insights - Vimarsana News

US Dermatologists' Lack of Success with Current Treatment Options in Vitiligo Paves the Way for Pipeline Advanced Systemic Agents to Disrupt the Market, According to Spherix Global Insights

/PRNewswire/ -- Vitiligo is a disease that causes loss of skin color in patches when cells that produce melanin die or stop functioning.1 Spherix recently...

New Research on Alopecia Areata Reveals Vast Potential for Eli Lilly's Recently Approved Olumiant Across Both the US and EU5, According to Spherix Global Insights - Vimarsana News

New Research on Alopecia Areata Reveals Vast Potential for Eli Lilly's Recently Approved Olumiant Across Both the US and EU5, According to Spherix Global Insights

/PRNewswire/ -- Spherix recently surveyed 200 EU-based dermatologists across France, Germany, Italy, Spain, and the UK and followed up with ten qualitative...

New Research on Alopecia Areata Reveals Vast Potential for Eli Lilly's Recently Approved Olumiant Across Both the US and EU5, According to Spherix Global Insights - Vimarsana News

New Research on Alopecia Areata Reveals Vast Potential for Eli Lilly's Recently Approved Olumiant Across Both the US and EU5, According to Spherix Global Insights

/PRNewswire/ -- Spherix recently surveyed 200 EU-based dermatologists across France, Germany, Italy, Spain, and the UK and followed up with ten qualitative...

Spherix Research Reveals Rheumatologists Taking the Lead Over Nephrologists in Both BENLYSTA (GlaxoSmithKline) and LUPKYNIS (Aurinia) Patient Initiations in Lupus Nephritis - Vimarsana News

Spherix Research Reveals Rheumatologists Taking the Lead Over Nephrologists in Both BENLYSTA (GlaxoSmithKline) and LUPKYNIS (Aurinia) Patient Initiations in Lupus Nephritis

/PRNewswire/ -- With the approvals of GlaxoSmithKline's Benlysta in lupus nephritis (LN) at the end of 2020 and Aurinia's Lupkynis at the beginning of 2021,...

Vyvgart's Novel Mechanism of Action and Efficacy Are Top Advantages of the Brand, According to Neurologists Surveyed by Spherix Global Insights - Vimarsana News

Vyvgart's Novel Mechanism of Action and Efficacy Are Top Advantages of the Brand, According to Neurologists Surveyed by Spherix Global Insights

/PRNewswire/ -- Three months into the launch of argenx's Vyvgart for generalized myasthenia gravis (gMG) in patients who are anti-acetylcholine receptor...